Medpace Holdings Inc (MEDP)
Activity ratios
Short-term
Turnover ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | 6.37 | 6.20 | 6.24 | 6.24 | 5.88 | 5.57 | 5.71 | 5.41 | 6.14 | 5.87 | 6.37 | 5.97 | 5.76 | 6.68 | 6.93 | 6.53 | 5.53 | 5.87 | 5.25 | 5.73 |
| Payables turnover | 47.85 | 49.37 | 39.65 | 33.48 | 35.15 | 38.92 | 35.97 | 38.60 | 36.13 | 35.10 | 35.26 | 35.73 | 28.14 | 44.92 | 48.15 | 42.46 | 31.29 | 32.15 | 27.80 | 43.93 |
| Working capital turnover | — | — | — | — | — | — | — | — | 8.57 | 8.82 | 13.28 | 11.10 | 27.62 | 24.48 | — | — | — | — | — | — |
Inventory turnover data is not available for Medpace Holdings Inc. However, looking at the receivables turnover ratio, we observe a consistent improvement from 5.76 in Q4 2022 to 6.32 in Q4 2023, indicating that the company is collecting its receivables more efficiently over time.
The payables turnover ratio also shows variability, with a peak of 44.04 in Q3 2023 and a low of 29.62 in Q1 2023. This suggests fluctuations in how quickly the company pays its suppliers.
Unfortunately, no data is provided for the working capital turnover ratio, so we cannot assess the efficiency of the company in generating revenue relative to its working capital.
Overall, Medpace Holdings Inc seems to be effectively managing its receivables and payables turnover, which can positively impact its cash flow and operational efficiency.
Average number of days
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Days of sales outstanding (DSO) | days | 57.33 | 58.83 | 58.46 | 58.52 | 62.13 | 65.55 | 63.91 | 67.46 | 59.42 | 62.18 | 57.29 | 61.12 | 63.42 | 54.61 | 52.68 | 55.86 | 65.99 | 62.16 | 69.57 | 63.74 |
| Number of days of payables | days | 7.63 | 7.39 | 9.21 | 10.90 | 10.38 | 9.38 | 10.15 | 9.46 | 10.10 | 10.40 | 10.35 | 10.21 | 12.97 | 8.13 | 7.58 | 8.60 | 11.66 | 11.35 | 13.13 | 8.31 |
Days of inventory on hand (DOH) for Medpace Holdings Inc is not provided in the table, which limits our ability to assess the efficiency of managing inventory. However, focusing on Days of Sales Outstanding (DSO), we observe a decreasing trend from Q4 2022 to Q4 2023, indicating the company is collecting its accounts receivable faster over time.
Regarding the number of days of payables, there is a fluctuating pattern in the payment period to suppliers. The trend shows a decrease in Q3 and Q4 of 2023 compared to the same periods in 2022. This implies that Medpace may be paying its suppliers more quickly.
Overall, the company appears to be efficiently managing its accounts receivable and payables, which can positively impact its cash flow and working capital management.
Long-term
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fixed asset turnover | 15.75 | 15.83 | 14.96 | 14.13 | 13.55 | 13.25 | 12.45 | 12.34 | 12.29 | 12.47 | 11.94 | 11.31 | 10.90 | 12.54 | 13.37 | 17.82 | 18.21 | 18.83 | 19.78 | 19.72 |
| Total asset turnover | 1.15 | 1.22 | 1.22 | 1.15 | 1.10 | 1.04 | 0.98 | 0.90 | 0.69 | 0.69 | 0.70 | 0.66 | 0.67 | 0.69 | 0.72 | 0.78 | 0.75 | 0.77 | 0.77 | 0.74 |
Long-term activity ratios provide insight into how effectively a company is utilizing its assets to generate revenue. In the case of Medpace Holdings Inc, we can analyze the fixed asset turnover and total asset turnover ratios over the past eight quarters.
1. Fixed Asset Turnover:
- The fixed asset turnover ratio increased steadily from Q1 2022 to Q4 2023, indicating that Medpace Holdings Inc is generating more revenue relative to its investment in fixed assets.
- The company's fixed asset turnover ranged from 12.31 to 15.64 over this period, with Q4 2023 showing the highest efficiency in utilizing fixed assets to generate sales.
- This trend suggests that Medpace Holdings Inc has been improving its operational efficiency and maximizing the productivity of its fixed assets.
2. Total Asset Turnover:
- The total asset turnover ratio varied over the quarters, but generally showed an increasing trend from Q1 2022 to Q4 2023.
- The total asset turnover ranged from 0.90 to 1.20 during this period, with Q3 2023 recording the highest turnover.
- The increasing total asset turnover indicates that Medpace Holdings Inc is utilizing its total assets more efficiently to generate sales revenue, which can be a positive sign of operational effectiveness and asset utilization.
Overall, the long-term activity ratios of Medpace Holdings Inc suggest that the company has been improving its efficiency in generating revenue from both fixed and total assets over the analyzed period. This enhanced asset utilization can contribute to the company's overall financial performance and profitability.